非酒精性脂肪性肝病防治指南(2018年更新版)

被引：581

作者：

National Workshop on Fatty Liver and Alcoholic Liver Disease

Chinese Society of Hepatology

Chinese Medical Association

Fatty Liver Expert Committee

Chinese Medical Doctor Association

机构：

[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组

[2] 中国医师协会脂肪性肝病专家委员会

来源：

临床肝胆病杂志 | 2018年 / 34卷 / 05期

关键词：

脂肪肝; 诊断; 治疗; 诊疗准则;

D O I：

暂无

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

1002 ; 100201 ;

摘要：

<正>非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是一种与胰岛素抵抗(insulin resistance,IR)和遗传易感密切相关的代谢应激性肝损伤,疾病谱包括非酒精性肝脂肪变、非酒精性脂肪性肝炎(non-alcoholic steatohepatitis,NASH)、肝硬化和肝细胞癌(hepatocellular carcinoma,HCC)[1-2]。NAFLD不

引用

页码：947 / 957

页数：11

共 27 条

[1]

FibroTouch与FibroScan肝脏硬度和脂肪定量检测效能的比较.[J].曾静;孙婉璐;陈光榆;潘勤;颜士岩;孙超;徐正婕;范建高;.中华肝脏病杂志.2016, 09

[2]

细胞角蛋白-18联合受控衰减参数二步法无创鉴别非酒精性脂肪性肝炎的临床研究.[J].沈峰;郑瑞丹;宓余强;施军平;王晓颖;胡锡琪;潘勤;徐雷鸣;范建高;.中华肝脏病杂志.2016, 06

[3]

Prevalence of fatty liver disease and the economy in China: A systematic review.[J].Jin-Zhou Zhu;Qin-Yi Zhou;Yu-Ming Wang;Yi-Ning Dai;Jiang Zhu;Chao-Hui Yu;You-Ming Li;.World Journal of Gastroenterology.2015, 18

[4]

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.[J].Feng Shen;Rui-Dan Zheng;Yu-Qiang Mi;Xiao-Ying Wang;Qin Pan;Guang-Yu Chen;Hai-Xia Cao;Ming-Li Chen;Liang Xu;Jian-Neng Chen;Yi Cao;Rui-Nan Zhang;Lei-Ming Xu;Jian-Gao Fan;.World Journal of Gastroenterology.2014, 16

[5]

肝脏炎症及其防治专家共识.[J].王宇明;于乐成;.中华肝脏病杂志.2014, 02

[6] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].

Armstrong, Matthew James ;

Gaunt, Piers ;

Aithal, Guruprasad P. ;

Barton, Darren ;

Hull, Diana ;

Parker, Richard ;

Hazlehurst, Jonathan M. ;

Guo, Kathy ;

Abouda, George ;

Aldersley, Mark A. ;

Stocken, Deborah ;

Gough, Stephen C. ;

Tomlinson, Jeremy W. ;

Brown, Rachel M. ;

Huebscher, Stefan G. ;

Newsome, Philip N. .

LANCET, 2016, 387 (10019) :679-690

[7] Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis [J].

Ballestri, Stefano ;

Zona, Stefano ;

Targher, Giovanni ;

Romagnoli, Dante ;

Baldelli, Enrica ;

Nascimbeni, Fabio ;

Roverato, Alberto ;

Guaraldi, Giovanni ;

Lonardo, Amedeo .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) :936-944

[8] Long-Term Clinical Outcomes After Fatty Liver Screening in Patients Undergoing Coronary Angiogram: A Prospective Cohort Study [J].

Wong, Vincent Wai-Sun ;

Wong, Grace Lai-Hung ;

Yeung, Judy Ching-Lam ;

Fung, Chloe Yuk-Kiu ;

Chan, Jasmine Ka-Lei ;

Chang, Zoe Hoi-Yi ;

Kwan, Chelsia Tsz-Yan ;

Lam, Hiu-Wan ;

Limquiaco, Jenny ;

Chim, Angel Mei-Ling ;

Yu, Cheuk-Man ;

Chan, Henry Lik-Yuen .

HEPATOLOGY, 2016, 63 (03) :754-763

[9] Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease [J].

Shen, Feng ;

Zheng, Rui-Dan ;

Shi, Jun-Ping ;

Mi, Yu-Qiang ;

Chen, Guo-Feng ;

Hu, Xiqi ;

Liu, Yong-Gang ;

Wang, Xiao-Ying ;

Pan, Qin ;

Chen, Guang-Yu ;

Chen, Jian-Neng ;

Xu, Liang ;

Zhang, Rui-Nan ;

Xu, Lei-Ming ;

Fan, Jian-Gao .

LIVER INTERNATIONAL, 2015, 35 (11) :2392-2400

[10] Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial [J].

Neuschwander-Tetri, Brent A. ;

Loomba, Rohit ;

Sanyal, Arun J. ;

Lavine, Joel E. ;

Van Natta, Mark L. ;

Abdelmalek, Manal F. ;

Chalasani, Naga ;

Dasarathy, Srinivasan ;

Diehl, Anna Mae ;

Hameed, Bilal ;

Kowdley, Kris V. ;

McCullough, Arthur ;

Terrault, Norah ;

Clark, Jeanne M. ;

Tonascia, James ;

Brunt, Elizabeth M. ;

Kleiner, David E. ;

Doo, Edward .

LANCET, 2015, 385 (9972) :956-965

← 1 2 3 →